Janet S Rader

10PUBLICATIONS
44CO-AUTHORS
Molecular targetsCancer geneticsPredictive and prognostic markersPharmacogenomicsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 17, 2026
TAOK3 inhibition constrains invasion, potentiates paclitaxel, and reprograms the tumor microenvironment toward anti-tumor immunity in cervical cancer.

|Dec 05, 2024
Rearrangements of viral and human genomes at human papillomavirus integration events and their allele-specific impacts on cancer genome regulation.

Vanessa L Porter, Michelle Ng, Kieran O'Neill

|Nov 14, 2023
Genomic structures and regulation patterns at HPV integration sites in cervical cancer.

Vanessa L Porter, Kieran O'Neill, Signe MacLennan

|Jun 06, 2023
A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors.

Todd M Bauer, Kathleen N Moore, Janet S Rader

|Sep 16, 2021
Multi-omics mapping of human papillomavirus integration sites illuminates novel cervical cancer target genes.

Marissa Iden, Shirng-Wern Tsaih, Yi-Wen Huang

|Aug 12, 2021
Oncostatin M Receptor-Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth.

Anjali Geethadevi, Ajay Nair, Deepak Parashar

Pageof 2

Frequent Collaborators

4 joint publications

Marissa Iden

3 joint publications

Deepak Parashar

3 joint publications

Bindu Nair

2 joint publications

Vanessa L Porter